| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 76.888 | 70.293 | 85.780 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 76.888 | 79.132 | 85.983 |
| Total Expenses - EUR | - | - | - | - | - | - | 606 | 12.573 | 51.878 | 110.319 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -606 | 64.315 | 27.254 | -24.336 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -606 | 62.693 | 26.472 | -26.916 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Shieldstark Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 17.665 | 104.105 | 84.727 |
| Current Assets | - | - | - | - | - | - | 99 | 60.543 | 24.565 | 27.300 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 49.690 | 12.407 | 25 |
| Cash | - | - | - | - | - | - | 99 | 10.852 | 12.158 | 27.275 |
| Shareholders Funds | - | - | - | - | - | - | -566 | 62.125 | 26.520 | -20.429 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 888 | 16.275 | 103.329 | 133.069 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Shieldstark Medical S.r.l.